X-154030627-TGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGG-TGGTGGGG

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_001110792.2(MECP2):​c.1203_1236delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACC​(p.Pro402AlafsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P401P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., 0 hem., cov: 17)
Exomes 𝑓: 0.0000050 ( 0 hom. 3 hem. )
Failed GnomAD Quality Control

Consequence

MECP2
NM_001110792.2 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 3.50

Publications

2 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 95 pathogenic variants in the truncated region.
PP5
Variant X-154030627-TGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGA-T is Pathogenic according to our data. Variant chrX-154030627-TGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGA-T is described in ClinVar as Pathogenic. ClinVar VariationId is 143411.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.1203_1236delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro402AlafsTer8
frameshift
Exon 3 of 3NP_001104262.1
MECP2
NM_004992.4
MANE Plus Clinical
c.1167_1200delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro390AlafsTer8
frameshift
Exon 4 of 4NP_004983.1
MECP2
NM_001316337.2
c.888_921delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro297AlafsTer8
frameshift
Exon 5 of 5NP_001303266.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.1203_1236delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro402AlafsTer8
frameshift
Exon 3 of 3ENSP00000395535.2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.1167_1200delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro390AlafsTer8
frameshift
Exon 4 of 4ENSP00000301948.6
MECP2
ENST00000630151.3
TSL:5
c.1167_1200delTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACCp.Pro390AlafsTer8
frameshift
Exon 4 of 4ENSP00000486089.2

Frequencies

GnomAD3 genomes
AF:
0.0000126
AC:
1
AN:
79310
Hom.:
0
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000240
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000501
AC:
5
AN:
998687
Hom.:
0
AF XY:
0.00000930
AC XY:
3
AN XY:
322629
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
23812
American (AMR)
AF:
0.00
AC:
0
AN:
33118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22417
South Asian (SAS)
AF:
0.00
AC:
0
AN:
50842
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
27210
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3457
European-Non Finnish (NFE)
AF:
0.00000639
AC:
5
AN:
782048
Other (OTH)
AF:
0.00
AC:
0
AN:
39771
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000126
AC:
1
AN:
79310
Hom.:
0
Cov.:
17
AF XY:
0.00
AC XY:
0
AN XY:
18894
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
20025
American (AMR)
AF:
0.00
AC:
0
AN:
6750
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2466
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1475
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3186
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
188
European-Non Finnish (NFE)
AF:
0.0000240
AC:
1
AN:
41592
Other (OTH)
AF:
0.00
AC:
0
AN:
982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Rett syndrome Pathogenic:2
Sep 05, 2002
RettBASE
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

Mar 20, 2024
Centre for Population Genomics, CPG
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant is absent from gnomAD (PM2_Supporting). Has been observed in at least 2 individuals with phenotypes consistent with MECP2-related disease (PS4_Supporting). ClinVar Variation ID: 143411, PMID 12075485, PMID 19914908

Severe neonatal-onset encephalopathy with microcephaly Pathogenic:1
Feb 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Pro390Alafs*8) in the MECP2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 97 amino acid(s) of the MECP2 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Rett syndrome (PMID: 12075485, 19914908). ClinVar contains an entry for this variant (Variation ID: 143411). This variant disrupts a region of the MECP2 protein in which other variant(s) (p.Tyr450Leufs*37) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.5
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608343; hg19: chrX-153296078; API